Arcturus Therapeutics Holdings, Inc. (ARCT)

8.87 -0.26 (-2.85%) USD  |  NASDAQ  |  May 07, 14:34
More

Arcturus Therapeutics Holdings SG&A Expense (TTM) : 46.08M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ARCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Twist Bioscience Corp. 196.87M
STAAR Surgical Co. 185.99M
Denali Therapeutics, Inc. 136.56M
Quantum-Si, Inc. 44.75M
Agenus, Inc. 54.39M